1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Broncus Holding Corporation
  6. Summary
    2216   KYG1609T1022

BRONCUS HOLDING CORPORATION

(2216)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-08 am EDT
2.580 HKD   -0.77%
08/05Dire performance of new Hong Kong listings clouds prospects for IPO pickup
RE
07/19Broncus Holding Completes Surgeries on Pulmonary Patients Using Thermal Vapor Treatment
MT
07/18Broncus Holding Corporation Completes Surgeries on the First Group of Patients Using Its InterVapor, the Thermal Vapor Treatment System, After Approved for Marketing in China
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
08/02/2022 08/03/2022 08/04/2022 08/05/2022 08/08/2022 Date
2.6(c) 2.6(c) 2.6(c) 2.6(c) 2.58 Last
113 500 1 087 500 76 000 1 124 000 302 500 Volume
+1.56% 0.00% 0.00% 0.00% -0.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 19,3 M - -
Net income 2022 -40,1 M - -
Net cash position 2022 186 M - -
P/E ratio 2022 -3,82x
Yield 2022 -
Sales 2023 38,0 M - -
Net income 2023 -35,6 M - -
Net cash position 2023 261 M - -
P/E ratio 2023 -3,97x
Yield 2023 -
Capitalization 174 M 174 M -
EV / Sales 2022 -0,62x
EV / Sales 2023 -2,28x
Nbr of Employees 300
Free-Float 65,2%
More Financials
Company
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions... 
More about the company
Ratings of Broncus Holding Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BRONCUS HOLDING CORPORATION
08/05Dire performance of new Hong Kong listings clouds prospects for IPO pickup
RE
07/19Broncus Holding Completes Surgeries on Pulmonary Patients Using Thermal Vapor Treatment
MT
07/18Broncus Holding Corporation Completes Surgeries on the First Group of Patients Using It..
CI
03/29Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 3..
CI
03/28Broncus Holding Corporation Announces Resignation of Wen Hao Wang as Chief Financial Of..
CI
03/28Broncus Holding Corporation Announces Resignation of Wen Hao Wang as Joint Company Secr..
CI
03/25Certain Ordinary Shares of Broncus Holding Corporation are subject to a Lock-Up Agreeme..
CI
03/21Hong Kong Stocks Extend Slide; Broncus Shares Jump 8%
MT
03/21China Approves Market Launch of Broncus' Vapor Treatment System; Shares Rise 9%
MT
03/20BRONCUS HOLDING CORPORATION(SEHK : 2216) added to S&P Global BMI Index
CI
03/20Broncus Holding Corporation's InterVapor® Receives Approval by the National Medical Pro..
CI
2021Broncus Completes Enrollment for Clinical Trials of Lung Cancer Treatment in China
MT
2021Broncus Holding Corporation announces Enrollment for Registered Clinical Trials Success..
CI
2021Broncus to Invest $3 Million in Member of Consortium for New Frontier Health's Go-Priva..
MT
2021Unicorn Holding Partners LP announced that it expects to receive $3 million in funding ..
CI
More news
News in other languages on BRONCUS HOLDING CORPORATION
07/18Broncus Holding Corporation achève les opérations chirurgicales sur le premier groupe d..
03/29Broncus Holding Corporation annonce ses résultats pour l'année complète se terminant le..
03/28Broncus Holding Corporation annonce la démission de Wen Hao Wang en tant que co-secréta..
03/21Les actions de Hong Kong prolongent leur chute ; les actions de Broncus bondissent de 8..
03/21La Chine approuve la mise sur le marché du système de traitement des vapeurs de Broncus..
More news
Chart BRONCUS HOLDING CORPORATION
Duration : Period :
Broncus Holding Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRONCUS HOLDING CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 0,33 $
Average target price 1,13 $
Spread / Average Target 243%
EPS Revisions
Managers and Directors
Guo Wei Zhan Chief Executive Officer & Executive Director
Yi Wei Zhao Chairman
Hong Xu Executive Director & Chief Technology Officer
Pok Man Kam Independent Non-Executive Director
Wan Yee Lau Independent Non-Executive Director
Sector and Competitors